Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Getwell Pharmaceuticals is a research-driven Indian pharmaceutical company primarily focused on the oncology segment. The company manufactures and markets a diverse range of high-quality generic formulations, including cytotoxic injectables, tablets, and capsules. With WHO-GMP certified manufacturing facilities, Getwell serves both domestic and international markets, providing affordable treatment options for cancer, critical care, and gastroenterology. They also offer contract manufacturing and development services to various global pharmaceutical entities. Their portfolio includes a wide array of anti-cancer drugs such as paclitaxel, oxaliplatin, and gefitinib. The company is headquartered in Gurugram, India, and maintains a strong distribution network across several emerging markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Getwell Pharma.